Editorial
Editor-in-Chief
Scott R. Evans, Director of the George Washington Biostatistics Center, Milken Institute of Public Health, George Washington University, Washington, D.C. (sevans@bsc.gwu.edu)
Editors
Alfred Balch, University of Utah, Salt Lake City, UT, (Alfred.Balch@hsc.utah.edu)
Brad J. Biggerstaff, Division of Vector-Borne Diseases (DVBD), Centers for Disease Control and Prevention, Fort Collins, CO, (bkb5@cdc.gov)
Ron Bosch, Harvard T.H.Chan School of Public Health, Boston, MA, (ronbosch@sdac.harvard.edu)
Ivan S.F. Chan, Bristol Myers Squibb, New York, NY, (Ivan.Chan@bms.com)
Guoqing Diao, George Washington University, Washington, D.C. (gdiao@gwu.edu)
Xiao Ding, Vir Biotechnology, Inc., San Francisco, CA, (xding@vir.bio)
Marian G. Ewell, The EMMES Corporation, Rockville, MD, (mewell@emmes.com)
Dean Follmann, Biostatistics Research Branch (BRB), Division of Clinical Research (DCR), NIAID, Rockville, MD, (DFollmann@niaid.nih.gov)
Ron Fricker, Virginia Tech, Blacksburg, VA, (fricker@vt.edu)
Toshimitsu Hamasaki, George Washington University, Washington, D.C., (hamasaki@bsc.gwu.edu)
Judith Lok, Boston University – Mathematics & Statistics, Boston, MA, (jjlok@math.bu.edu)
Olga Marchenko, Therapeutic Area Statistics PAOW at Bayer, Morristown, NJ, (olga.marchenko@bayer.com)
Devan V. Mehrotra, Merck & Co., Inc., North Wales, PA,(devan_mehrotra@merck.com)
Farzad Noubary, Bouvé College of Health Sciences, Northeastern University, Boston, MA, (f.noubary@northeastern.edu)
Dionne L. Price, Office of Biostatistics, Center for Drug Evaluation and Research, (CDER), FDA, Silver Spring, MD, (Dionne.Price@fda.hhs.gov)
Cavan Reilly, Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN, (cavanr@biostat.umn.edu)
Barbra Richardson, Department of Biostatistics, University of Washington, Seattle, WA, (barbrar@uw.edu)
Dan Rubin, Office of Biostatistics, Center for Drug Evaluation and Research, FDA, Silver Spring, MD, (Daniel.Rubin@fda.hhs.gov)
Pamela Shaw, Department of Biostatistics, Epidemiology, and Informatics (DBEI), Perelman School of Medicine (PSOM), University of Pennsylvania, Philadelphia, PA, (shawp@mail.med.upenn.edu)
Norma Terrin, Biostatistics, Epidemiology, and Research Design (BERD) Center, Tufts University School of Medicine, Boston, MA,(Nterrin@tuftsmedicalcenter.org)
Lu Tian, Department of Health Research and Policy, Stanford University, Stanford, CA, (lutian@stanford.edu)
Kohei Uemura, Department of Biostatistics and Bioinformatics, Tokyo University, Tokyo, Japan, (kohei.uemura@iii.u-tokyo.ac.jp)
Handan Wand, University of New South Wales, The Kirby Institute, Kensington, NSW, Australia (Hwand@kirby.unsw.edu.au)
Rui Wang, Harvard Pilgrim Health Care Institute (HPHCI), Department of Population Medicine, Boston, MA, (ruiwang29@gmail.com)
Hulin Wu, UTHealth School of Biomedical Informatics (SBMI), University of Texas Health Science Center, Houston, TX, (Hulin.Wu@uth.tmc.edu)
Gene Pennello, Center for Devices and Radiological Health, FDA, Silver Spring, MD, (Gene.Pennello@fda.hhs.gov)